With the continued consolidation trend in the life science industry and increased pressures on R&D investment, the Contract Research Organization (CRO) is poised to be an even more important strategic outsourcing partner. This evolution is coupled with the growing complexities of conducting preclinical and clinical studies and the implementation of increasingly stringent regulations.
CROs are gaining momentum as a major player within the healthcare space, driven by financial and risk mitigation pressures, as well as regulatory scrutiny. As pharmaceutical and biotechnology companies continue to outsource drug discovery and development, CROs will continue to grow and have a need for enterprise quality management software (EQMS) technologies like TrackWise to manage all critical quality and compliance processes using a single, centralized system.
The need to measure and ensure quality is vital throughout all aspects of the clinical trial process. TrackWise enterprise quality management software provides a flexible and configurable platform for tracking and managing quality and compliance events to ensure that clinical research activities are continually measured, monitored and improved upon.
The TrackWise Preclinical GLP Auditing Solution, featuring the Audit Execution Package, is designed to facilitate the processes involved with GLP auditing in addition to providing the standard quality, compliance and workflow management capabilities of TrackWise.
The TrackWise Clinical GCP Auditing Solution, featuring the Audit Execution Package, is designed to facilitate the processes involved with GCP auditing in addition to providing the standard quality, compliance and workflow management capabilities of TrackWise.
TrackWise Clinical Trial Management software enables companies to improve efficiency, integrity, and quality of clinical trials by automating and streamlining workflow processes and increasing the visibility of related tasks and data, allowing the sponsor organization to streamline processes, appropriately respond to current statuses and proactively manage their trials.